Literature DB >> 6347786

Irradiation protects against pancreatic islet degeneration and hyperglycaemia following streptozotocin treatment of mice.

M Nedergaard, J Egeberg, H Kromann.   

Abstract

Five daily injections of streptozotocin (40 mg/kg) produce islet inflammation, necrosis of pancreatic B cells and hyperglycaemia in the mouse. Anti-pancreatic autoimmunity has been suggested as part of the cause of these events. We have studied the possible effect of total-body irradiation in long-term studies (246 days) and report here that insulitis, islet necrosis and insulin depletion are reduced after irradiation. In parallel the level of hyperglycaemia is reduced. It is concluded that immunological mechanisms are to some extent responsible for the development of streptozotocin-induced diabetes.

Entities:  

Mesh:

Year:  1983        PMID: 6347786     DOI: 10.1007/bf00251829

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies.

Authors:  A A Like; M C Appel; R M Williams; A A Rossini
Journal:  Lab Invest       Date:  1978-04       Impact factor: 5.662

2.  A differential stain for cell types in the pancreatic islets.

Authors:  G Gomori
Journal:  Am J Pathol       Date:  1939-07       Impact factor: 4.307

3.  The influence of the major histocompatibility complex (H-2) on experimental diabetes in mice.

Authors:  H Kromann; A Lernmark; B F Vestergaard; J Egeberg; J Nerup
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

4.  An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus.

Authors:  K Junker; J Egeberg; H Kromann; J Nerup
Journal:  Acta Pathol Microbiol Scand A       Date:  1977-09

5.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

6.  Streptozotocin-induced diabetes in athymic and conventional BALB/c mice.

Authors:  G Beattie; R Lannom; J Lipsick; N O Kaplan; A G Osler
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

7.  Sex differences in the multiple-dose streptozotocin model of diabetes.

Authors:  A A Rossini; R M Williams; M C Appel; A A Like
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

8.  Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.

Authors:  S G Paik; N Fleischer; S I Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

10.  The low dose streptozotocin murine model of type 1 (insulin-dependent) diabetes mellitus: studies in vivo and in vitro of the modulating effect of sex hormones.

Authors:  H Kromann; M Christy; A Lernmark; M Nedergaard; J Nerup
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

View more
  5 in total

1.  Abnormal lymphocyte function precedes hyperglycaemia in mice treated with multiple low doses of streptozotocin.

Authors:  M Itoh; M Funauchi; K Sato; S Kisamori; N Fukuma; Y Hirooka; N Nihei
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

2.  Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice.

Authors:  J R Wright; J B Lefkowith; G Schreiner; P E Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice.

Authors:  N Hatamori; K Yokono; M Hayakawa; T Taki; W Ogawa; M Nagata; J Hari; K Shii; H Taniguchi; S Baba
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

4.  Multiple low-dose streptozotocin-induced diabetes in the mouse: further evidence for involvement of an anti-B cell cytotoxic cellular auto-immune response.

Authors:  R C McEvoy; N M Thomas; C Hellerström; F Ginsberg-Fellner; T M Moran
Journal:  Diabetologia       Date:  1987-04       Impact factor: 10.122

5.  The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility.

Authors:  J R Wright; B Haliburton; H Russell; M Henry; R Fraser; H W Cook
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.